JAMA Oncol 2024 Mar 28
Neoadjuvant Dual Checkpoint Inhibitors vs Anti-PD1 Therapy in High-Risk Resectable Melanoma: A Pooled Analysis.
Related Questions
New comment by Medical Oncologist at SSM Health Medical Group ( June 11, 2024)
Yes, most of the cases I was referred to are found to be node-positive at SLN biopsy rather than clinically positive nodes. Thank you